2014 | Medical Innovation Summit

Now, it's Personal

Cancer Treatment and Personalized Medicine October 27-29, 2014 Cleveland, Ohio

 

Featured Speakers

| View All Speakers

Christopher Connor

Chairman & CEO

The Sherwin-Williams Company

Christopher Connor | Chairman & CEO ,

Christopher M. Connor is Chairman and Chief Executive Officer of The Sherwin-Williams Company, a $10 Billion Global Leader in the Paint and Coatings Industry.  Mr. Connor was elected Chief Executive Officer by the Company’s Board of Directors on October 25, 1999 and added the title of Chairman on April 26, 2000.

Mr. Connor, 58, began his employment with The Sherwin-Williams Company in 1983 as Director of Advertising for the Paint Stores Group.  Over his 31-year career with Sherwin-Williams, Mr. Connor has held a number of increasingly important assignments in many different functional areas of the Company.  In every one of these assignments he has been privileged to work with the outstanding men and women of Sherwin-Williams as they have prospered and grown the Company together. 

Today, Sherwin-Williams operates over 3,900 paint stores in the United States, owns many of the paint and coatings industry leading brand names, and sells products in over 115 countries around the world. 
Sherwin-Williams’ culture of excellence has created an environment where outstanding technology, strong marketing, operational excellence and engagement all continue to play a role in the Company’s growing success.  Sherwin-Williams has been recognized by many business publications for financial excellence, integrity of business practices, strong track record of dividend payments and notably, by Fortune Magazine, as one of our nation’s top 100 companies to work for on three separate occasions. 

In addition to The Sherwin-Williams Company Board of Directors, Mr. Connor serves on the board of the Eaton Corporation and the Federal Reserve Bank of Cleveland.  His many civic and community board engagements include the Rock and Roll Hall of Fame and Museum, The Playhouse Square Foundation, University Hospitals Health System, United Way Services of Greater Cleveland, Fisher College of Business at The Ohio State University, the National Association of  Manufacturers, The American Coatings Association and the Greater Cleveland Partnership.

Mr. Connor is a 1974 graduate of Walsh Jesuit High School and a 1978 graduate of The Ohio State University.  He and his wife, Sara, have three adult children.
 

Ginni Rometty

Chairman, President & CEO

IBM

Ginni Rometty | Chairman, President & CEO ,

Ginni Rometty is Chairman, President and Chief Executive Officer of IBM. Mrs. Rometty was appointed President and CEO effective January 1, 2012. She became Chairman of the Board of Directors on October 1, 2012.

Mrs. Rometty began her career with IBM in 1981 in Detroit, Michigan. Since then she has held a series of leadership positions in IBM, most recently as Senior Vice President and Group Executive, IBM Sales, Marketing and Strategy. In this role, she was responsible for business results in the 170 global markets in which IBM operates and pioneered IBM's rapid expansion in the emerging economies of the world.

Prior to this, Mrs. Rometty served as Senior Vice President, IBM Global Business Services, where she led the successful integration of PricewaterhouseCoopers Consulting. This acquisition was the largest in professional services history, creating a global team of more than 100,000 business consultants and services experts. In recognition of her leadership in the professional services industry, Mrs. Rometty was honored with the Carl Sloane Award 2006, given by the Association of Management Consulting Firms.

In prior leadership roles, Mrs. Rometty served as general manager of IBM Global Services, Americas, as well as general manager of IBM's Global Insurance and Financial Services Sector.

Mrs. Rometty serves on the Council on Foreign Relations; the Board of Trustees of Northwestern University; and the Board of Overseers and Board of Managers of Memorial Sloan-Kettering Cancer Center.

She holds a Bachelor of Science degree with high honors in computer science and electrical engineering from Northwestern University.

Twitter Handle: @IBM

Fred Hassan

Managing Director

Warburg Pincus

Fred Hassan | Managing Director ,

Fred Hassan is a Partner and Managing Director with the private equity firm, Warburg Pincus. He is also a Board member of Time Warner.
 
Fred Hassan is the former Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation. Prior to joining Schering-Plough in April 2003, Hassan was Chairman and Chief Executive Officer of Pharmacia Corporation – a company that was formed in March 2000 as a result of the merger of Monsanto and Pharmacia and Upjohn. Hassan joined Pharmacia & Upjohn as Chief Executive Officer in 1997.
 
Previously, Hassan was Executive Vice President of Wyeth, with responsibility for its pharmaceutical and medical products business. He was elected to Wyeth’s Board of Directors in 1995. Earlier in his career, Hassan spent 17 years with Sandoz Pharmaceuticals (now Novartis) and headed its U.S. pharmaceuticals business.
 
Hassan received a B.S. degree in chemical engineering from the Imperial College of Science and Technology at the University of London and an M.B.A. from Harvard Business School. Hassan has chaired significant pharmaceutical industry organizations including The Pharmaceutical Research and Manufacturers of America (PhRMA) and The International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Mr. Hassan is also a member of The Business Council.
 
Fred Hassan’s book, “Reinvent -  A Leader’s Playbook for Serial Success” was published in February 2013 by Wiley and has been discussed in many global organizations including the World Bank.  In 2014 he was selected by a CNBC panel among the top 200 people who have had a profound influence in the past quarter century.

Why Attend?

The Medical Innovation Summit provides an unrivaled perspective on the newest medical innovations and the financial drivers behind those innovations. The conference is recognized for providing singular insights, networking opportunities and actionable take away for all participants. The content is designed for:

  • Senior executives in the healthcare industry
  • Clinical, medical affairs, regulatory and business development executives
  • Venture capitalists and angel investor groups
  • Investment bankers
  • Buy-side and sell-side researchers
  • Consulting, legal and other service providers

Agenda Highlights

Sunday | October 26th
  • Innovation Base Camp
Monday | October 27th
  • New Ventures Healthcare Challenge
  • Cleveland Clinic Tours
  • The State of Healthcare Innovation
  • Dinner and One-on-One with Jeff Immelt, Chairman and CEO, General Electric
Tuesday | October 28th
  • The Business of Cancer Risks
  • Personalized Medicine Today
  • Healthcare Transformer Showcase
  • Lunch and One-on-One with Robert Bradway, Chairman and CEO, Amgen
  • Imaging and Health IT
  • Networking Recepton
Wednesday | October 29th
  • The Next Generation of Drug Development
  • Top 10 Medical Innovations for 2015
  • Lunch and One-on-One with Ginni Rometty, Chairman, President and CEO, IBM

2014 Sponsors

View All Past Sponsors

PREMIER
SPONSORS
PLATINUM
SPONSORS